Estrovera
This product looks safe
- No ingredients exceed tolerable upper intake levels
- Limited research evidence available for ingredients
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
Supplement Facts — Evidence Check
Other Ingredients
Label Claims — Verification
Target Groups
Product Information
📋 Directions for Use
Directions: Take one tablet with food and a glass of water once daily at the same time of day or as directed by your healthcare practitioner.
Simple dosing Well-tolerated, once-daily tablet
⚠️ Warnings & Precautions
Notice: Do not use if you have or develop diarrhea, loose stools or abdominal pain because rhubarb may worsen these conditions and be harmful to your health. Consult your physician if you have frequent diarrhea.
Caution: Do not use if pregnant or nursing. If taking medication, consult your healthcare practitioner before use.
🧪 Formulation Notes
Featuring ERr 731
Also known as Siberian rhubarb root
Estrovera's key ingredients, ERr 731, has been used safely and effectively for over 20 years and is supported by clinical studies. Estrovera provides relief for multiple menopausal symptoms, including hot flashes, sleep disturbances, mood swings, irritability, anxiety, and sexual problems.
This product is non-GMO, gluten-free, and vegetarian.
This product is non-GMO, gluten-free, and vegetarian.
Highly efficacious Formulated with ERr 731, which has shown up to 83% reduction in menopausal symptoms Percentages are estimated and not included in the studies. For more information please visit MetaDispensary.com. Exceptional safety profile ERr 731 recommended by healthcare professionals in Europe since 1993 This estimate ratio is not included in the publication of cumulative results of a 12-week study followed by 2 48-week observation studies (OS). It is calculated from the mean change of the MRS II total score of 5.7 at the end of the first 48-week OS divided by the baseline score of 34. There was no change in total score from the end of the first OS to the end of the second OS. These results are from the ERr 731 subgroup only, which was administered ERr 731 daily for a total of 108 weeks. This calculation does not take into account some changes in study population over time.
Extensively studied Multiple well-designed randomized double-blind placebo-controlled studies
Certified Gluten Free GFCO.org (Gluten-Free Certification Organization)
83% decrease in daily hot flashes ERr 731 delivers non-hormonal hot flash relief, with up to an 83% decrease in daily hot flashes and other menopausal symptoms Kaszkin-Bettag M, Ventskovsky BM, Solskyy S, et al. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms. Altern Ther Health Med. 2009; 15(1):24-34.
Additional Information
8 7-Tablet Bottles
Visit MetaDispensary.com for additional information.
Storage: Keep tightly closed in a cool, dry place.
Please recycle
Certified Gluten Free GFCO.org (Gluten-Free Certification Organization)
12-week study of 112 perimenopausal women ERr 731 subjects reported a significant decrease in the medium number of daily hot flashes compared to subjects taking placebo
Number of Daily Hot Flashes Baseline Placebo 12 ERr 731 12 12 Weeks Placebo 13 ERr 731 2
Product Details
Research Evidence
We're building the evidence profile for this product's ingredients.
Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.